| Nov 4 |
Big Pharma’s Obesity Bonanza Faces New Tests
|
| Nov 4 |
Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024
|
| Nov 4 |
Viking shares jump after positive early data on oral obesity pill; Lilly, Novo drop
|
| Nov 1 |
Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
|
| Oct 31 |
This High-Flying Stock Just Became a Better Buy
|
| Oct 30 |
Viking Therapeutics CFO Cashes Out: $10M in Shares Sold Amidst Stock Surge
|
| Oct 29 |
Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.
|
| Oct 28 |
Viking Therapeutics: Lots Of Positives
|
| Oct 28 |
Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024
|
| Oct 27 |
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
|
